Kestra Medical Technologies, Ltd. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Kestra Medical Technologies, Ltd. (KMTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 779.83 thousand shares for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2026-07-31 was 779.83K shares, a 38.27% decline year-over-year.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2026-04-30 was 206.54K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2026-01-31 was 197.58K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2025-10-31 was 988.23K shares.
- Kestra Medical Technologies, Ltd. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2026 was 2.66M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2026-07-31 | 779.83K shares 10-Q · filed 2026-09-14 | 986.37K shares derived: sum of 2 quarters · filed 2026-09-14 | 1.18M shares derived: sum of 3 quarters · filed 2026-09-14 | 2.17M shares derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | 206.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | 404.12K shares derived: sum of 2 quarters · filed 2026-07-14 | 1.39M shares derived: sum of 3 quarters · filed 2026-07-14 | 2.66M shares 10-K · filed 2026-07-14 |
| 2026-01-31 | 197.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | 1.19M shares derived: sum of 2 quarters · filed 2026-03-17 | 2.45M shares 10-Q · filed 2026-03-17 | |
| 2025-10-31 | 988.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | 2.25M shares 10-Q · filed 2025-12-11 | ||
| 2025-07-31 | 1.26M shares 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |